Greater Manchester backs move to outcome-based payment
The trend towards paying for medicines based on patient outcomes (OBP) are growing in both the US and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Feb 19
The trend towards paying for medicines based on patient outcomes (OBP) are growing in both the US and…
13 Feb 19
A new world-first, digital tracking system covering the medicines supply chain across the EU has gone live, promising…
13 Feb 19
The FDA is cracking down on those selling dietary supplement and has sent warning letters to companies who…
03 Feb 15
A new drug that treats moderate-to severe binge eating disorder (BED) in adults has been approved by FDA,…
03 Feb 15
A new drug that treats moderate-to severe binge eating disorder (BED) in adults has been approved by FDA,…
28 Jan 15
The European Commission has granted clearance for a three-part transaction between GlaxoSmithKline (GSK) and Novartis. The proposal includes…
21 Feb 14
Lucentis® (ranibizumab) has been approved by Japanese regulatory bodies for a fourth indication: the treatment of patients with…